Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting Piezo1 channel as promising new therapeutic strategy in prostate cancer

Oct. 15, 2019

GalNAc-siTAZ improves hepatic inflammation, fibrosis and liver damage in models of NASH

Oct. 15, 2019

Novel GET zebrafish larvae model of invasive mycoses

Oct. 15, 2019

ALKBH proteins are potential therapeutic targets in HNSCC

Oct. 15, 2019

ReNeuron announces phase I/IIa data on hRPC stem cell therapy in retinitis pigmentosa

Oct. 14, 2019

[68Ga]FAPI-04 imaging evaluated in studies in cancer patients

Oct. 14, 2019

Kodiak reports phase Ib data on KSI-301 in wet AMD, DME and RVO

Oct. 14, 2019

Auris reports phase Ib interim data on AM-201 for antipsychotic-induced weight gain and somnolence

Oct. 14, 2019

Eyevensys provides initial data from phase I/II study of EYS-606 for noninfectious uveitis

Oct. 14, 2019

RegenxBio presents phase I/IIa interim data on RGX-314 in wet AMD

Oct. 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...